Mehveş Poda

Natural history of SMA IIIb

Feza Deymeer, Yeşim Parman, Mehveş Poda · Neurology · 2008 · 61 citations

Mapping of the second Friedreich's ataxia (FRDAff2) locus to chromosome 9p23-p11: evidence for further locus heterogeneity

Kyproula Christodoulou, Feza Deymeer, Coşkun Özdemır et al. · Neurogenetics · 2001 · 41 citations

Neurodegenerative Diseases, Mendelian Disorder, Genetic Disorder +7

Gender-modulated impact of apolipoprotein A5 gene (APOA5) −1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults

Evrim Kömürcü-Bayrak, Altan Onat, Mehveş Poda et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2008 · 39 citations

The S447X variant of lipoprotein lipase gene is associated with metabolic syndrome and lipid levels among Turks

Evrim Kömürcü-Bayrak, Altan Onat, Mehveş Poda et al. · Clinica Chimica Acta · 2007 · 33 citations

Obesity, Metabolic Syndrome, Lipoprotein Lipase Gene +11

Segmental distribution of muscle weakness in SMA III: implications for deterioration in muscle strength with time1This work was presented at the New Challenges in Neuromuscular Disorders, 25–27 September 1996, London, UK.1

Feza Deymeer, Mehveş Poda, Yeşim Gülşen-Parman et al. · Neuromuscular Disorders · 1997 · 30 citations

Muscle Function, Neuromuscular Coordination, Kinesiology +17